Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001735276-23-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-14 | 2023-02-10 | ALNY | Vaishnaw Akshay | Pres | S - Sale+OE | $215.97 | -38.0K | 38.7K | -50% | -$8.22M |
| D | 2023-02-14 | 2023-02-10 | ALNY | Vaishnaw Akshay | Pres | M - OptEx | $63.00 | +30.9K | 53.0K | +140% | +$1.95M |
| D | 2023-02-14 | 2023-02-10 | ALNY | Vaishnaw Akshay | Pres | M - OptEx | $0.00 | -30.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | S | D | 1,709 | $213.13 | 51,305 | D | — | — | (F2) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $212.71 to $213.70. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2023-02-10 | S | D | 2,307 | $214.28 | 48,998 | D | — | — | (F3) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $213.72 to $214.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Common | Common Stock | 2023-02-10 | S | D | 19,447 | $216.38 | 19,272 | D | — | — | (F5) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $215.89 to $216.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 4 | Common | Common Stock | 2023-02-10 | S | D | 4,302 | $217.05 | 14,970 | D | — | — | (F6) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $216.96 to $217.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 5 | Common | Common Stock | 2023-02-10 | M | A | 30,913 | $63.00 | 53,014 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-10 | S | D | 10,279 | $215.59 | 38,719 | D | — | — | (F4) The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $214.88 to $215.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 7 | Derivative | Stock Option (right to buy) | 2023-02-10 | M | D | 30,913 | $0.00 | 0 | D | $63.00 · — to 2023-12-18 | 30,913 Common Stock | (F8) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |